← Back to portal Open roadmap

Prospective Validation, Impact Studies and Randomized Evaluation

A model can look excellent in retrospective data and still fail to improve care when it reaches real clinicians, patients, and workflows. This guide helps students move from "does the model predict well?" to "does the tool change decisions safely, fairly, and usefully in the real world?"

Beginner Learn the difference between retrospective testing, silent prospective validation, and real clinical impact.

Intermediate Compare pilot studies, before-after designs, interrupted rollouts, and pragmatic evaluations.

Advanced Think about contamination, behavior change, implementation outcomes, stepped-wedge trials, and safety monitoring.

3 Core stages: silent validation, workflow use, and outcome impact

Action Impact starts only when a prediction changes what somebody actually does

Fit The right study design depends on urgency, workflow disruption, and how quickly outcomes appear

Why this page matters

The portal already covers train-test splitting, external validation, calibration, deployment monitoring, and workflow integration. The next major gap is prospective evidence: how to test an ML tool before and after clinicians can see it, and how to measure whether it improves care rather than just predicting well.

Core idea: discrimination and calibration tell you how predictions behave. Prospective validation asks whether the prediction arrives in time, gets used, changes behavior, and leads to better or safer outcomes.

Common mistake: treating an observational before-after improvement as proof that the model caused the improvement. Real workflows change for many reasons at once.

Three levels of evidence

Beginner

Can the model still predict prospectively?

First ask whether performance remains acceptable when time truly moves forward and staff cannot influence the labels yet.

Use silent or shadow mode before showing predictions to users.
Check that timestamps, missingness, and data availability still behave as expected.
Look for performance drops caused by workflow drift or delayed data entry.

Intermediate

Do people use the output in the intended way?

The next question is implementation: who sees the output, whether they trust it, and whether it changes real decisions.

Track alert opens, overrides, acceptance, and turnaround time.
Measure workload fit, not just AUROC.
Expect behavior changes even if the model itself stays fixed.

Advanced

Does the tool improve patient, operational, or equity outcomes?

Strong evidence often needs a design that separates model impact from secular trends, co-interventions, and local enthusiasm.

Choose outcomes that can plausibly change through the tool.
Plan safety, subgroup, and unintended consequence monitoring.
Consider randomized, cluster-randomized, or stepped-wedge rollout when causal claims matter.

Evaluation ladder from offline to real-world impact

Students often jump from retrospective AUC directly to deployment. A safer path is to climb the evidence ladder step by step.

Retrospective validation

Check discrimination, calibration, leakage, subgroup performance, and external validity in historical data.

Silent prospective run

Generate predictions in real time without showing them to clinicians. Confirm data flow, timing, and stability.

Workflow pilot

Expose the output to a small service or team. Measure usage, burden, trust, and operational fit.

Comparative impact study

Use a design that can separate model effect from background change: concurrent controls, cluster rollout, or randomization.

Post-launch monitoring

Keep measuring adoption, drift, alert burden, safety outcomes, and fairness after implementation.

Interactive study design lab

Select a health ML use case and inspect which prospective study choice is a reasonable next step. The lesson is not that one design is always best, but that the correct design depends on workflow, timing, contamination risk, and how quickly meaningful outcomes appear.

Prospective evaluation simulator

Emergency department sepsis alert

Silent run Best first prospective step

Cluster trial Strong comparison design

Time to antibiotics Plausible primary outcome

Alarm fatigue Key safety watch-out

Design pressure points

Workflow disruption High

Contamination risk High

Outcome delay Low

Design note

High-urgency alerts can affect team behavior quickly, so silent validation is useful first, but causal impact may still need concurrent comparison because staffing and seasonality also change outcomes.

Check if the prediction appears early enough to change action.
Monitor how often clinicians ignore or override alerts.
Use concurrent comparison if workflow or seasonal trends are strong.

Outcome menu: what should an impact study measure?

A single study may need process outcomes, patient outcomes, and implementation outcomes. Different outcomes answer different questions.

Process outcomes

These change fastest and are often the first realistic target.

Time to antibiotics, imaging turnaround, referral completion, chart review time.
Useful for early pilots and workflow redesign.
Need a believable link to patient benefit.

Patient outcomes

These matter most, but they may be delayed or influenced by many co-interventions.

Mortality, ICU transfer, readmission, length of stay, adverse events.
Often need larger samples or longer follow-up.
Hard to interpret without strong causal design.

Implementation outcomes

These explain why a tool succeeds or fails even when performance looks acceptable.

Adoption, fidelity, trust, acceptability, workload burden, override rate.
Critical for mixed-method evaluations.
Often reveal failure earlier than clinical endpoints.

Safety and equity outcomes

Always pre-specify harm checks, especially when automation changes triage or treatment.

Missed urgent cases, delayed care, unfair prioritization, alert fatigue.
Track subgroup differences prospectively, not only retrospectively.
Include a rollback or pause plan.

When randomized evaluation is worth the effort

Use stronger causal designs when:

The claim is that the tool improves outcomes, not just predictions.
Background trends, staffing, or policy changes can easily bias before-after comparisons.
The intervention affects shared team behavior, making contamination likely.
Leadership needs high-confidence evidence before scaling system-wide.

Common practical options

Silent trial: good for data flow and timing checks.
Concurrent non-randomized comparison: faster, weaker causal inference.
Cluster randomization: useful across wards, clinics, or hospitals.
Stepped-wedge rollout: pragmatic when everyone will eventually receive the tool.

Questions advanced students should ask

Who is actually randomized: patient, clinician, ward, or hospital?
Could clinicians change behavior even in the control arm?
How will missing follow-up, override behavior, and exposure fidelity be measured?
What happens if the model or workflow changes mid-study?

Quick self-check

Use these cases to test whether you can match the evaluation question to a sensible prospective design.

Case 1

A sepsis model is now generating scores in real time, but clinicians cannot see them yet. What is the main purpose of this stage?

Main purpose: silent prospective validation. You are checking timing, data flow, and prospective performance before the model can change clinician behavior.

Case 2

A hospital sees better outcomes after an ML triage tool launches, but staffing also increased and a new protocol started. What is the main threat to causal interpretation?

Main threat: confounding by co-interventions and time trends. A simple before-after comparison cannot separate the tool from other simultaneous changes.

Case 3

A readmission tool gives case managers a daily ranked list. Which outcome is often more realistic for an early pilot than 30-day mortality?

Better early pilot outcome: process or implementation outcomes such as review completion, outreach success, or time to contact, because they change sooner and are closer to the intervention.

How this connects to other portal pages

Before this page

Review external validation and transportability to understand whether the model generalizes before testing it prospectively.

Workflow linkage

Use clinical workflow integration to think about who acts on the prediction and how the intervention enters care.

After launch

Continue with deployment, monitoring, and model drift for post-implementation surveillance and lifecycle management.